Your browser doesn't support javascript.
loading
Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents.
Aziz, Marwa A; Serya, Rabah A T; Lasheen, Deena S; Abdel-Aziz, Amal Kamal; Esmat, Ahmed; Mansour, Ahmed M; Singab, Abdel Nasser B; Abouzid, Khaled A M.
Afiliación
  • Aziz MA; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt.
  • Serya RA; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt.
  • Lasheen DS; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt.
  • Abdel-Aziz AK; Center for Drug Discovery and Development Research, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt.
  • Esmat A; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt.
  • Mansour AM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt.
  • Singab AN; Center for Drug Discovery and Development Research, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt.
  • Abouzid KA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
Sci Rep ; 6: 24460, 2016 Apr 15.
Article en En | MEDLINE | ID: mdl-27080011

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ornitina / Pirimidinas / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Descubrimiento de Drogas / Furanos / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2016 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ornitina / Pirimidinas / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Descubrimiento de Drogas / Furanos / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2016 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Reino Unido